NASDAQ:TELO | Operating Income | Telomir Pharmaceuticals, Inc.

Complete source-backed operating income history.

Available history
2024-03-31 to 2025-03-31
Data captured

Historical Operating Income

DateOperating Income
2025-03-31$2.19M
2024-03-31$1.92M

Annual Operating Income

DateOperating Income

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.